A randomized study of the effect of patient positioning on setup reproducibility and dose distribution to organs at risk in radiotherapy of rectal cancer patients by unknown
RESEARCH Open Access
A randomized study of the effect of patient
positioning on setup reproducibility and
dose distribution to organs at risk in
radiotherapy of rectal cancer patients
Trude C. Frøseth1, Trond Strickert1, Kjersti S. Solli1, Øyvind Salvesen2, Gunilla Frykholm3 and Randi J. Reidunsdatter4*
Abstract
Background: The patient positioning in pelvic radiotherapy (RT) should be decided based on both reproducibility
and on which position that yields the lowest radiation dose to the organs at risk (OAR), and thereby less side
effects to patients. The present randomized study aimed to evaluate the influence of patient positioning on setup
reproducibility and dose distribution to OAR in rectal cancer patients.
Methods: Ninety-one patients were randomized into receiving RT in either supine or prone position. The
recruitment period was from 2005 to 2008. Position deviations were derived from electronic portal image
registrations, and setup errors were defined as deviations between the expected and the actual position of bony




 were calculated. The estimated lengths of v→

 defined the main outcome and were compared between
prone and supine positions using linear mixed model statistics. The mean volume of each 5 Gy increments
between 5 and 45 Gy was calculated for the small bowel and the total bowel, and the dose volumes were
compared between prone and supine position.
Results and conclusion: Data from 83 patients was evaluable. The mean v
→

 was 5.8 mm in supine position and
7.1 mm in prone position (p = 0.024), hence the reproducibility was significantly superior in supine position.
However, the difference was marginal and may have borderline clinical importance. The irradiated volumes of the
small bowel and the total bowel were largest in the supine position for all dose levels, but none of those were
significantly different. The patient positioning in RT of rectal cancer patients may therefore be decided based on
other factors such as the most comfortable position for the patients.
Introduction
Colorectal cancer is the second most common type of
cancer in Europe, and rectal cancer accounts for a third
of colorectal cancer cases [1]. Radiotherapy (RT) in com-
bination with chemotherapy has become the standard
adjuvant or neoadjuvant treatment for locally advanced
rectal cancer [2, 3]. The efficacy of adjuvant therapies
has been demonstrated, in which the addition of chemo-
radiotherapy (CRT) has specifically reduced the rate of
recurrence and improved the survival rate compared to
surgery alone [4]. However, this regimen is associated
with acute and late small bowel complications that may
severely influence the patient’s quality of life [5, 6].
The ultimate goal of RT is to deliver a prescribed dose
to a target volume precisely while minimizing dose to the
surrounding healthy tissues. To account for the geomet-
rical uncertainties in delivering the target dose the clinical
target volume (CTV) is expanded by a total margin (TM)
to obtain the planning target volume (PTV). The uncer-
tainties are usually classified as external setup deviations
and internal organ movement. Nijkamp et al. quantified
the inter-fraction shape variation of the mesorectum of
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the CTV and found that the differences were small
between prone and supine treatments [7]. It follows
that the patient setup reproducibility is crucial for the
precision of the dose delivery. Reproducibility may be
influenced by several factors, such as the physical
condition of the patient [8], body mass index (BMI)
[9, 10], use of immobilization devices [8], and whether pa-
tients are treated in the prone or supine position [11, 12].
Although the prone position has been preferred in
order to minimize irradiated bowel volume [13], system-
atic reproducibility deviations are reported to occur
more frequently in this position. The supine position has
been associated with more interfractional variation (i.e.,
random errors) than the prone position [11, 14]. Only
one randomized study has investigated patient reprodu-
cibility in pelvic RT, and the authors reported that
prone position required most corrections [12]. Previ-
ous studies addressing the issues of reproducibility in
RT of pelvic malignancies have focused mainly on
prostate cancer patients [11, 12], and the results may
not be readily generalizable to patients with advanced
rectal cancer.
The small bowel, the total bowel and the urinary blad-
der are the most important organs at risk (OAR) in pel-
vic radiation. The small bowel is the most radiosensitive
and dose-limiting normal structure [13, 15]; conse-
quently, diarrhoea is the most common acute side effect
of pelvic RT [16–18]. Of patients receiving CRT for rec-
tal cancer, 10 % had to interrupt the scheduled course of
RT due to acute gastrointestinal (GI) side effects [15].
Among the more serious late side effects are chronic
diarrhoea, perforation, intestinal obstruction, ulceration,
fistulas, changed bowel frequency and faecal incontin-
ence [5, 6, 19].
Standard conventional RT to the pelvic region involves
irradiation of a considerable volume of small bowel.
Several studies have shown associations between dose
volumes of the small bowel and acute diarrhoea in pa-
tients treated for rectal cancer [16, 17, 20, 21]. Diarrhoea
was significantly associated with small bowel volume at
all dose levels during preoperative CRT [16, 17, 21], and
was strongest associated with volumes receiving doses
larger than 15 Gy [16, 20–22]. Furthermore, patients
with acute diarrhea (grade 2+ and grade 3+) had signifi-
cantly larger irradiated small bowel volumes [16, 21].
Given the high level of bowel toxicity in rectal cancer
patients and the documented association between toxicity
and dose volumes of the small bowel [16, 17, 20, 21],
the optimal delivery of RT is important. The most
optimal patient positioning should be based on both
patient reproducibility and which position yields the
lowest possible radiation dose to the OAR and thereby
fewer side effects to patients [7]. Therefore, we conducted
a prospective randomized clinical study that chiefly aimed
to evaluate the effect of patients’ positioning on both setup
errors and dose distribution to the OAR.
Materials and methods
From November 2005 to December 2008, 146 patients
with locally advanced rectal cancer from two hospitals in
mid-Norway were invited to participate. Inclusion cri-
teria were the ability to be treated in either the supine or
prone position, a WHO performance status of 0 to 2,
having both lower limbs intact, and having no hip pros-
thesis. The study was approved by the regional research
ethics committee. After providing written informed con-
sent, participants were randomized into prone or supine
positioning using block randomization and stratified ac-
cording to pre- or postoperative RT. Sample size calcula-
tion using two-sample t-test estimated that 35 participants
in each group were needed to detect a mean difference of
5 mm in the displacement vector in order to provide stat-
istical power of 80 %. The recruitment flowchart is shown
in Fig. 1.
Treatment planning
Computer tomography (CT) scans (3 mm slice thick-
ness) of the whole abdomen and pelvis were obtained in
the treatment position. Standard commercial immobili-
zation devices were applied. In the supine position, pa-
tients were positioned with a pillow under their heads,
knee and ankle support pillows, and their arms resting on
their chests. In the prone position, patients were posi-
tioned with a pillow under their heads, ankle support pil-
lows, and their arms above their heads. The patients were
instructed to empty the bladder one hour before the CT
scanning. Gastrografin solution (900 mL) was given orally
one hour before scanning to better visualize the bowel for
delineation.
A radio-opaque lead pellet anal marker was placed
ventrally on the anal verge by an oncologist, and 95 mL
intravenous contrast solution (Omnipaque 350 mgI/mL)
was given to visualize the vessels. Long lines for align-
ment were drawn along the three laser lines projected
on the patient’s skin. The CT images were imported to
the dose planning system (Oncentra MasterPlan v 3.3,
Nucletron B.V., Veenendaal, The Netherlands) and the
pencil beam algorithm was used for dose calculation.
The gross tumour volume (GTV), the CTV and the in-
ternal target volume (ITV) were delineated in each CT
slice, and the PTV was created according to national
guidelines [2]. The internal margin (IM) for creating an
ITV was 5 mm in all directions except from the ventral
direction, where the margin was 10 mm. The setup mar-
gin was 5 mm. CTV included GTV with 10 mm margin
(= CTV boost), the mesorectum and the locoregional
lymph nodes presacrally, and lymph nodes along the
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internal iliac vessels up to a cranial border defined by
iliaca communis.
The small bowel and the total bowel were delineated
in every CT slice by contouring the outer extensions of
theirs loops and thereby defining the total volume occu-
pied by the organs (Fig. 2). The cranial border of the
organs was outlined at the level where the duodenum
meets the jejunum. The caudal border was set at the
upper level of GTV for preoperative patients and in the
upper level of CTV for postoperative patients. The def-
inition of the small bowel did not include the volume of
CTV boost because it is a part of the target volume and
not an OAR. The urinary bladder was defined by its
outer walls.
The notations V5, V10, etc. are used for the volume
that receives a dose of 5 Gy or more, 10 Gy or more,
etc. The volumes (cm3) of small bowel receiving doses in
5 Gy increments from 5 to 45 Gy were calculated using
the dose volume histograms (DVH). The calculations
were based on the initial pelvic field that received a total
dose of 46 Gy because the boost field (up to 54 Gy) did
not include the small bowel. Radiation treatment was
planned and delivered using a 3-D conformal technique,
with either three or four MLC-shaped conform fields
delivered by 6 MV or 15 MV photon beams, depending
on the proximity of the PTV to the patient’s posterior
skin surface. Preoperatively, a mean dose of 46 Gy was
given to the ITV in 23 daily fractions, followed by a
boost of 4 or 8 Gy to the macroscopic tumour including
10 mm margins. Postoperative RT was delivered by 50 Gy
to the ITV in 25 fractions [2].
On the treatment simulator, the isocenter of the
planned RT beams was identified and the orientation of
the simulator beams were verified against reference
digitally reconstructed radiogram (DRR) images. Treat-
ment electronic portal images (EPIs) were obtained of
the posterior and lateral treatment fields with iView GT
EPID (Elekta, Crawley, UK) and were analysed with
image-based verification software (VISIR, Nucletron B.V.,
Veenendaal, the Netherlands). The EPIs were registered
a b
Fig. 2 Axial view of a patient showing the small bowel (yellow) and the total bowel (red) in the prone position a and the supine position b
Excluded (n= 55) : 
Did not meet inclusion criteria (n= 22)
Refused to participate (n= 20)
Treatment at another centre (n= 13)
Assessed for eligibility (n=146)
Randomized (n= 91)
Excluded (n= 6) : 
Stoma (n= 2)
Comorbidity complications (n= 1)
Another treatment  after inclusion (n= 1)
Withdrawal (n=2)




Excluded (n= 2) : 
Another treatment after inclusion (n= 1)
Treatment at another centre (n= 1)
Analyzed prone position (n= 40) Analyzed supine position (n= 43)
Fig. 1 Recruitment flowchart
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with the reference DRRs from the treatment plan.
DRR-EPI matching was based upon the identification
and outlining of bony landmarks in the pelvic region
by two dedicated observers. The linea terminalis and
foramen obturatum were delineated in the frontal
projection, whereas the ventral part of the sacrum,
the acetabulum, and the promontorium were used for
lateral beam directions.
Setup errors were defined as deviations between the
expected (DRR) and the actual position of the bony
landmarks. Setup deviations were translated into table
shift values Δ x, Δ y, and Δ z in the three orthogonal di-
rections in a treatment table-oriented coordinate system
that corresponded to the lateral, longitudinal, and verti-
cal directions of the table. Setup errors without protocol
corrections (intrinsic values) were utilized to cultivate
the effect of positioning (removing the protocol effect). In-
trinsic values were obtained by adding the foregoing cor-
rections to the measured values. For each measurement,





Δx2 þ Δy2 þ Δz2
p
The length of this deviation vector was compared
between the prone and supine positions.
Statistical analysis
The dataset consisted of repeated observations of the
setup error vector (i.e., the response variable). The mea-
surements of each patient were made at irregular times
(i.e., fractions) according to the interventions dictated by
the verification protocol. The logarithmic transform of
the vector length was approximately normally distrib-
uted and used as the dependent variable in the analysis.
A linear mixed model (LMM) was used to examine the
effect of treatment positioning on the setup error vector.
The log-transformed vector length at fraction f for patient
id, Vf id, is specified as:
ln V f ;id
  ¼ βposition þ αid þ εf ;id
β is the regression coefficient for the treatment pos-
ition, and α represents the individual patient effects; αid
were assumed to be independent and identically nor-
mally distributed. The error terms for each patient ε f ,id
were assumed to be multivariate normally distributed
with a mean of zero and a covariance matrix defined by:
Σid ¼ σ2ρ f i−f jj j
h i
id
The AR1 autoregressive covariance structure modelled
the correlation within each patient. Error terms for dif-
ferent patients were assumed to be independent. The
impact of BMI and time (i.e. fraction number) on the
setup vector were also tested by including these factors
as covariates in the LMM.
Dose volumes and doses to OAR were characterized
by their mean values, SD and ranges. For the small
bowel and the total bowel, the mean volume of each
5 Gy increment between 5 and 45 Gy was calculated.
For the bladder, only V40 and V45 were calculated be-
cause of the higher dose tolerance of this organ. Dose
volumes were compared between the prone and supine
positions using two-sided independent t-tests.
Statistical analyses were carried out using Stata v.12
(StataCorp LP, College Station, TX, USA) and SPSS v.18
(IBM, Armonk, NY, USA).
Results
Of 91 randomized patients, 83 were included in the
study. Of these patients, 40 were treated in the prone
position and 43 in the supine position. Patient characteris-
tics are shown in Table 1. All patients received concomi-
tant chemotherapy (5-fluorouracil or Capecitabine), and
the great majority (94 %) received RT before surgery.
Patient BMI, calculated from their weight at the initial
visit, did not differ significantly between the two groups
(p = 0.29).
The effect of patient positioning on setup deviations
The mean number of observations per patient was 10.4
(range 6–18) for the prone position and 10.0 (range 7–17)
for the supine position. Measurements were made in 43 %
of the fractions. Mean deviation values were normally dis-
tributed, and the estimates (95 % CI) for the x, y and z di-
rections and the vector are shown in Table 2. The largest
Table 1 Patient characteristics
Total Supine Prone
No of patients 83 43 40
Preop 78 41 37
Postop 5 2 3
Patients with stoma 11 6 5
Sex
Male 54 29 25
Female 29 14 15
Age male (years)
Median 62 62 62
Range 32 – 81 32 – 81 49 – 81
Age female (years)
Median 63 63 64
Range 52 – 74 51 – 63 51 – 73
BMI (kg/m2)
Mean (SD) 26.5 (0.2) 26.9 (0.3)
Range 17.2 – 36.3 17.9 – 39.4
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errors were observed in the prone position in the vertical
direction.
Cumulative frequency distributions of the deviation
vectors illustrate larger deviations in the prone than in
the supine position. Frequencies of the greatest devia-
tions (>15 mm) were equal for the two positions (Fig. 3).
The estimated mean vector length (95 % CI) from LMM
analysis was 5.8 mm (5.1–6.6 mm) for the supine position
and 7.1 mm (6.3–8.1 mm) for the prone position. The
mean vector lengths for the two positions were signifi-
cantly different (p = 0.024).
The variance of the log-transformed values of patient
effects αid as estimated to be 0.372 (SE = 0.035), which
suggests considerable heterogeneous deviation vector
lengths among patients. Variance of the error terms, as a
measure of the variation in the setup deviation within
patients, was estimated to be 0.473 (SE = 0.013). The
correlation between error terms for adjacent fractions
within patients was estimated to be 0.28 (SE = 0.05),
which indicates that deviations measured closer in time
are more equal. Including time (i.e., fraction number) in
the model identified the significance (p < 0.001) of this
parameter in explaining the variance in the error term.
BMI showed a minor and insignificant contribution
(p = 0.45) explaining the observations. Both time and
BMI had negligible effects on the influence on patient
positioning on setup errors and were therefore excluded
in the final model.
The effect of patient positioning on dose distributions to
organs at risk
Dose distributions for OAR are presented in Table 3.
The dose variability was somewhat larger in the prone
than in the supine position, but there were no significant
differences in the mean doses to the small bowel (p = 0.85),
total bowel (p = 0.29) or urinary bladder (p = 0.74) between
the positions.
The mean defined total volume of the small bowel
(Table 3) was somewhat larger in the prone position
than in the supine position, while the mean dose volumes
at the different dose levels (V5–V45) (Table 4) were some-
what larger in the supine position than in the prone
position.
The dose-volume differences between the prone and
supine position increased with decreasing dose and ap-
peared largest at the low-dose volumes (V5 and V10,
Table 4). The mean dose-volume differences of the total
bowel varied across the dose levels. At V5 and V10, the
Table 2 Mean intrinsic set-up deviations for the lateral,
longitudinal and vertical directions
Mean value (mm) 95 % CIa
Lateral (Δ x)
Supine 0.4 [−0.8, 1.6]
Prone 0.4 [−0.6, 1.4]
Longitudinal (Δ y)
Supine 0.1 [−0.7, 0.8]
Prone - 0.3 [−1.3, 0.7]
Vertical (Δ z)
Supine 0.0 [−1.1, 1.1]
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Fig. 3 Cumulative frequency distributions of the total displacement vector for supine and prone treatment positions
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difference was largest in the supine position, while at
V15–V45, the difference appeared largest in the prone
position. However, none of these differences was statisti-
cally significant. The proportion of irradiated volumes at
each dose level was nearly identical in the prone and su-
pine positions.
Discussion
The present randomized study aimed to establish evi-
dence for the most optimal treatment position with re-
spect to reproducibility and lowest possible dose to OAR
in RT of rectal cancer patients. Patients were randomly
assigned to either prone or supine positioning. Setup
errors were expressed as displacement deviation vectors
calculated from table shift values without any protocol
corrections in the lateral, longitudinal and vertical direc-
tions. The length of this vector was compared between
the prone and supine positions. In addition, we explored
the dose distributions to OAR for both positions.
Statistically, supine positioning resulted in a significantly
smaller mean displacement vector than prone positioning
(p = 0.024), which indicates the superiority of supine posi-
tioning in regard to setup errors. Our results are suppor-
ted by two studies examining reproducibility in prostate
cancer patients [11, 12]. The only truly randomized study,
Bayley et al. [12], registered 2-D deviations using daily
pretreatment EPI and found that more corrections were
needed for patients treated in the prone position. Weber
et al. [11] examined 22 prostate patients in a positioning
study and reported less 2-D reproducibility for the prone
position. Patients with various pelvic malignancies were
included in two other studies [10, 14] in which a supine
position, overall, turned out to be favorable. In these stud-
ies, a belly board was consistently used in the prone pos-
ition, and there was no randomization regarding the
treatment position. Thus, comparisons with previous
studies are not straightforward, mainly due to their lack of
randomized design [10, 11, 14], small patient numbers
[11, 12, 14] and measurements confined to 2-D deviations
[11, 12].
Results from LMM analysis revealed substantial vari-
ability in the setup deviations both between patients and
within individual patients. Variability attributed to the
individual patient indicates the considerable influence of
random errors on setup deviations. The significant effect
of fraction number on set-up deviations confirms the in-
fluence of time. Increasing set-up errors by ascending
fraction number was also observed by el-Gayed [23]. De-
viations from the planning situation may be explained
by the patients becoming accustomed to the treatment
or that the general condition of each patient deteriorates
as treatment proceeds.
Table 3 Dose volume relations to organs at risk in patients lying in prone or supine position
Prone Supine

















Small bowel 5.8 ± 5.9 0.4 – 23.2 1451 361 - 2907 6.0 ± 5.2 0.6 - 20.0 1374 793 – 2204 0.85
Total bowel 5.8 ± 4.5 1.1 – 18.9 2977 1718 – 5365 4.8 ± 3.4 0.3 – 13.9 2973 1323 – 5454 0.29
Bladder 33.5 ± 11.7 6.9 – 46.3 211 45 – 647 32.6 ± 10.7 7.1 – 47.3 261 76 – 685 0.74
*Comparisons of mean doses to organs at risk between prone and supine position
Table 4 Dose volume distribution in small bowel and total bowel in prone and supine position
Small bowel Total bowel


























V5 250 ± 190 305 ± 238 20 23 0.25 486 ± 278 533 ± 326 18 18 0.49
V10 231 ± 189 272 ± 231 19 20 0.39 433 ± 261 460 ± 299 16 16 0.67
V15 159 ± 162 172 ± 198 13 13 0.75 346 ± 254 304 ± 293 13 10 0.49
V20 117 ± 148 124 ± 174 10 9 0.84 277 ± 242 223 ± 269 10 8 0.45
V25 96 ± 135 109 ± 156 8 8 0.70 243 ± 229 192 ± 227 9 6 0.31
V30 81 ± 119 94 ± 131 7 7 0.64 214 ± 206 165 ± 185 8 6 0.26
V35 71 ± 109 84 ± 117 6 6 0.60 192 ± 187 147 ± 163 7 5 0.25
V40 64 ± 102 76 ± 108 6 6 0.60 180 ± 178 135 ± 149 7 5 0.22
V45 50 ± 89 52 ± 74 4 4 0.90 141 ± 149 98 ± 105 6 3 0.14
*Comparisons of mean volumes to small bowel and total bowel between prone and supine position
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Patient BMI had a minor and insignificant contribu-
tion to modeling the data variability. This finding was
surprising because high BMI values (≥30 kg/m2) have
been associated with setup deviations in setup error
studies [9, 10], which also correspond to the common
view in clinical practice that correct positioning is more
challenging in obese patients. It might be that the influence
of BMI on setup deviations is modified by the patients’
“body firmness.” However, a valid measure of “firmness”
has not been introduced in clinical studies.
Setup errors in the prone position were statistically
significantly larger than in the supine position. However,
the expected difference between prone and supine vector
lengths was only 1.3 mm, which probably has marginal
clinical significance. We estimated that 35 participants
were required in each group in order to detect a vector
difference of 5 mm with a statistical power of 80 %. The
number of patients actually included in each group was
40 and 43, respectively. The LMM analysis with use of
all measurements within patients provided likely a
greater statistical power than the two-sample t-test used
in the initial power calculations based on one mean vector
length per participant.
Although the mean doses to the small bowel and total
bowel were not significantly different in our data, larger
variations were observed in the prone position. Drzymala
et al. [13] found that the mean low-dose volumes V5 and
V10 were significantly larger in the supine position in a
study of 19 patients receiving preoperative CRT for rectal
cancer who underwent CT scanning in both the prone
and supine positions. Studies utilizing a belly board device
have documented significantly lower doses to the small
bowel and a lower irradiated volume of small bowel in the
prone position than in the supine position [18, 24]. Our
insignificant results could be explained by large variations
within patients and by the fact that we did not employ a
belly board device. However, the benefit of small dose-
volume reductions using a belly board has to be consid-
ered against reduced reproducibility [8].
The irradiated volumes of the small bowel were largest
in the supine position for all dose levels; the differences
increased with decreasing dose and appeared largest at
the low dose volumes (V5 and V10). However, the pro-
portion of small bowel volume for all dose levels was
nearly identical in both positions. Consequently, the like-
lihood of bowel toxicity is expected to be similar in the
two groups. The architecture of the small bowel may be
considered as both serial with a dose-dependent risk in a
small volume and parallel with a significant correlation
between the irradiated volume and the likelihood of
acute toxicity [19]. A study of spinal cord in rats demon-
strated that high tolerance doses in small regions (shower)
decreased significantly when the adjacent tissue was irra-
diated with a subtolerance dose (bath) [25]. Based on the
“shower/bath” theory, not only the high dose volume but
also the dose distribution could be determining factors for
the risk of toxicity [25]. Although the mean volumes are
quite similar, there are relatively large variations in the
dose distributions among patients. Hence, it may be worth
investigating how the dose-volume distribution correlates
with both acute and late toxicity.
Doses to OAR are obviously influenced by the RT
technique employed. Volumetric-modulated arc therapy
(VMAT) techniques have demonstrated superiority in
terms of organs at risk sparing, e.g. small bowel [26].
The advantage of the VMAT technique is largest in post-
operative RT when the small bowel often is located in
the pelvis and moves less due to inflammatory reactions/
fibrosis. The 3D conformal RT is still a routine technique
in preoperative treatment. Though the doses to OAR
would have been reduced with a VMAT technique, the
impact of patient positioning on these doses would prob-
ably not been affected.
Our study examined both the small bowel and the
total bowel, whereas others have examined the small
bowel and the large bowel [20, 22] or only the small
bowel [16]. In the present study, we delineated the outer
extensions of the bowel loops, and thus defined the total
volume occupied by the organ. Some researchers have
defined the whole peritoneal cavity [17, 18, 20], whereas
others have identified every bowel loop [16, 21]. The latter
method results in less defined volume and provides a
more true volume of the organ. However, this procedure
is obviously more time consuming [18]. The various
methods of defining the bowel volumes may explain the
different reported associations between defined volumes
and acute side effects across studies, and may thus com-
plicate comparisons of the data.
Limitations and strengths
One limitation of the present study is that the measure-
ments of setup errors were made in only 43 % of the
fractions, which may represent a sampling bias. Belly
board immobilization could have yielded a smaller bowel
dose in the prone position. However, the possible gain
in dose reduction has to be weighed against the lack
of setup reproducibility by using belly board. The
small bowel is a mobile structure and could have
changed position during treatment. Cone Beam CT
would have provided better visualization of the bowel
position over time and would probably unveiled vari-
ability in dose delivering to OAR during treatment.
However, its clinical efficiency is not fully demonstra-
ted [27]. Excluding CTV from the bowel volume in
the postoperative irradiated patients could naturally
lead to a false lower bowel dose. However, these patients
were few and equally distributed in prone and supine
position.
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The strengths of the present study are its randomized
design and its relatively large number of participants. To
our knowledge, we are presenting the first study in rectal
cancer patients examining the effect of patient positioning
on both reproducibility and dose distributions to OAR.
Conclusions
Supine positioning is associated with significantly smaller
setup deviations than prone positioning in RT of rectal
cancer patients. However, the difference is small and may
have borderline clinical importance. Doses or dose vol-
umes to the small bowel were not significantly different
between the two positions. The optimal treatment pos-
ition for rectal cancer patients may, therefore, be safely
guided by practical considerations and individual factors,
such as the most comfortable position for the patient.
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